NDC 55111-404 Ranitidine

Tablet, Coated Oral - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
55111-404
Proprietary Name:
Ranitidine
Non-Proprietary Name: [1]
Ranitidine
Substance Name: [2]
Ranitidine Hydrochloride
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Labeler Name: [5]
    Dr. Reddy's Laboratories Limited
    Labeler Code:
    55111
    FDA Application Number: [6]
    ANDA078192
    Marketing Category: [8]
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date: [9]
    12-02-2009
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Navigator:

    Product Characteristics

    Color(s):
    PINK (C48328)
    Shape:
    ROUND (C48348)
    Size(s):
    9 MM
    Imprint(s):
    R150
    Score:
    1

    Product Packages

    NDC Code 55111-404-02

    Package Description: 1 BOTTLE in 1 CARTON / 200 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-17

    Package Description: 1 BLISTER PACK in 1 CARTON / 8 TABLET, COATED in 1 BLISTER PACK

    NDC Code 55111-404-24

    Package Description: 3 BLISTER PACK in 1 CARTON / 8 TABLET, COATED in 1 BLISTER PACK

    NDC Code 55111-404-32

    Package Description: 1 BOTTLE in 1 CARTON / 32 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-34

    Package Description: 1 BOTTLE in 1 CARTON / 24 TABLET, COATED in 1 BOTTLE

    Price per Unit: $0.09716 per EA

    NDC Code 55111-404-36

    Package Description: 1 BOTTLE in 1 CARTON / 36 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-38

    Package Description: 4 BLISTER PACK in 1 CARTON / 8 TABLET, COATED in 1 BLISTER PACK

    NDC Code 55111-404-40

    Package Description: 1 BOTTLE in 1 BOTTLE / 40 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-50

    Package Description: 1 BOTTLE in 1 CARTON / 50 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-55

    Package Description: 2 BOTTLE in 1 CARTON / 65 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-61

    Package Description: 1 BOTTLE in 1 CARTON / 65 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-62

    Package Description: 1 BOTTLE in 1 CARTON / 95 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-65

    Package Description: 1 BOTTLE in 1 CARTON / 220 TABLET, COATED in 1 BOTTLE

    NDC Code 55111-404-90

    Package Description: 2 BOTTLE in 1 CARTON / 95 TABLET, COATED in 1 BOTTLE

    Product Details

    What is NDC 55111-404?

    The NDC code 55111-404 is assigned by the FDA to the product Ranitidine which is a human over the counter drug product labeled by Dr. Reddy's Laboratories Limited. The product's dosage form is tablet, coated and is administered via oral form. The product is distributed in 14 packages with assigned NDC codes 55111-404-02 1 bottle in 1 carton / 200 tablet, coated in 1 bottle, 55111-404-17 1 blister pack in 1 carton / 8 tablet, coated in 1 blister pack, 55111-404-24 3 blister pack in 1 carton / 8 tablet, coated in 1 blister pack, 55111-404-32 1 bottle in 1 carton / 32 tablet, coated in 1 bottle, 55111-404-34 1 bottle in 1 carton / 24 tablet, coated in 1 bottle, 55111-404-36 1 bottle in 1 carton / 36 tablet, coated in 1 bottle, 55111-404-38 4 blister pack in 1 carton / 8 tablet, coated in 1 blister pack, 55111-404-40 1 bottle in 1 bottle / 40 tablet, coated in 1 bottle, 55111-404-50 1 bottle in 1 carton / 50 tablet, coated in 1 bottle, 55111-404-55 2 bottle in 1 carton / 65 tablet, coated in 1 bottle, 55111-404-61 1 bottle in 1 carton / 65 tablet, coated in 1 bottle, 55111-404-62 1 bottle in 1 carton / 95 tablet, coated in 1 bottle, 55111-404-65 1 bottle in 1 carton / 220 tablet, coated in 1 bottle, 55111-404-90 2 bottle in 1 carton / 95 tablet, coated in 1 bottle. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Ranitidine?

    Adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of waterto prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburncan be used up to twice daily (do not take more than 2 tablets in 24 hours)children under 12 years: ask a doctor

    What are Ranitidine Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • RANITIDINE HYDROCHLORIDE 150 mg/1 - A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.

    Which are Ranitidine UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Ranitidine Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Ranitidine?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    Which are the Pharmacologic Classes for Ranitidine?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".